Analytical and process development (PD/AD) strategies directly impact how quickly and reliably cell therapies reach patients.

A New Era in High-Throughput Flow Cytometry In today’s fast-paced drug discovery and screening environments, speed, prec | ...

Australian Patent Office accepts bioAffinity Technologies' patent application for its platform technology to assess lung health and predict disease.

Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...

A peak flow meter is a handheld device that measures airflow rate and can help those with respiratory conditions like asthma monitor their condition.

Affinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the Company’s commercially available test for early-stage ...

Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...

Naïve B cells exit quiescence and enter a proliferative state upon activation, ultimately differentiating into antibody-secreting or memory B cells. Toll-like receptor (TLR) ligands, such as ...

Flow is a state in which we feel fully focused, in the moment, and deeply alive. It requires us to fully engage our skills, and it can't be achieved if we keep checking our phones.

Affinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.

DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.

Fibrosis occurs when inflammation activates immune cells and fibroblasts to release collagen and cytokines that remodel and ...